Amneal Pharmaceuticals, Inc.
AMRXNASDAQHealthcare● Active
$13.71
$-0.04(-0.29%)
Market Cap$4.4B
P/E Ratio—
52W High$15.42
52W Low$7.53
Amneal Pharmaceuticals, Inc.（AMRX）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMRX · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.31B | $0.11B | $0.09B | $0.03B | $0.25B |
| Net Receivables | $0.94B | $0.78B | $0.65B | $0.74B | $0.69B |
| Inventory | $0.61B | $0.61B | $0.58B | $0.53B | $0.49B |
| Total Current Assets | $1.91B | $1.59B | $1.38B | $1.41B | $1.52B |
| PP&E Net | $0.55B | $0.52B | $0.55B | $0.59B | $0.64B |
| Goodwill | $0.60B | $0.60B | $0.60B | $0.60B | $0.59B |
| Intangible Assets | $0.56B | $0.73B | $0.89B | $1.10B | $1.17B |
| Total Assets | $3.68B | $3.50B | $3.47B | $3.80B | $3.94B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.32B | $0.21B | $0.09B | $0.03B |
| Accounts Payable | $0.25B | $0.26B | $0.14B | $0.17B | $0.13B |
| Total Current Liabilities | $0.88B | $1.13B | $0.85B | $0.75B | $0.68B |
| Long-Term Debt | $2.61B | $2.16B | $2.43B | $2.63B | $2.72B |
| Total Liabilities | $3.67B | $3.55B | $3.41B | $3.59B | $3.57B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.54B) | ($0.61B) | ($0.49B) | ($0.41B) | ($0.28B) |
| Total Stockholders Equity | ($0.07B) | ($0.11B) | $0.02B | $0.30B | $0.36B |
| Total Liab & Equity(computed) | $3.60B | $3.44B | $3.43B | $3.89B | $3.93B |
| Debt Summary | |||||
| Total Debt | $2.74B | $2.59B | $2.75B | $2.85B | $2.88B |
| Net Debt | $2.43B | $2.48B | $2.66B | $2.82B | $2.63B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Amneal Pharmaceuticals, Inc.
关于Amneal Pharmaceuticals, Inc.（AMRX）资产负债表
Amneal Pharmaceuticals, Inc.总资产$3.68B，现金及短期投资$0.31B，总负债$3.67B，总债务$2.74B，股东权益($0.07B)。
常见问题
AMRX · 4 问Amneal Pharmaceuticals, Inc.总债务$2.74B，净债务$2.43B。
AMRX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10